Pacer Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.12M Buy
261,483
+83,739
+47% +$2.05M 0.01% 612
2025
Q4
$4.76M Buy
177,744
+171,748
+2,864% +$4.42M 0.01% 728
2025
Q3
$160K Sell
5,996
-320,102
-98% -$8.27M ﹤0.01% 2041
2025
Q2
$7.49M Sell
326,098
-153,292
-32% -$3.8M 0.02% 573
2025
Q1
$13.9M Sell
479,390
-870,978
-64% -$27.8M 0.03% 395
2024
Q4
$50.1M Buy
1,350,368
+1,347,775
+51,977% +$61.6M 0.11% 203
2024
Q3
$126K Buy
2,593
+1,666
+180% +$73.1K ﹤0.01% 1951
2024
Q2
$37.1K Buy
927
+135
+17% +$5.59K ﹤0.01% 3289
2024
Q1
$34.8K Sell
792
-178
-18% -$9.19K ﹤0.01% 3314
2023
Q4
$60K Sell
970
-74
-7% -$3.89K ﹤0.01% 3052
2023
Q3
$48K Buy
1,044
+16
+2% +$873 ﹤0.01% 2479
2023
Q2
$59.1K Buy
+1,028
New +$45.6K ﹤0.01% 3053
2023
Q1
Sell
-231,009
Closed -$6.47M 2199
2022
Q4
$6.47M Buy
+231,009
New +$6.71M 0.03% 399
2022
Q3
Sell
-149,964
Closed -$5.22M 2120
2022
Q2
$5.22M Buy
+149,964
New +$5.35M 0.04% 361

Other funds holding AMPH